Olokizumab Antibody
Olokizumab (CDP-6038) is a humanized monoclonal antibody targeting interleukin-6 (IL-6) . It inhibits rheumatoid arthritis pathogenesis by selectively preventing the final assembly of the IL-6 signaling complex. This mechanism has been validated in both in vitro cellular assays and in vivo animal models of inflammatory disease.
Product Specifications
Product Name Alternative
CDP6038, CDP-6038, ILReceptor, IL-6, IL Receptor
Target
IL Receptor, Interleukin, STAT
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation, Signal Transduction, Stem Cell & Developmental Biology
Concentration
13.12 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
145.39 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Alpha 1 Catenin/CTNNA1 Rabbit Polyclonal Antibody (Fluoro550)
POU6F2, NT (POU6F2, RPF1, POU domain, class 6, transcription factor 2, Retina-derived POU domain factor 1) (APC)
POU6F2, NT (POU6F2, RPF1, POU domain, class 6, transcription factor 2, Retina-derived POU domain factor 1) (APC)